Nassif Mikheal purchased $4K of NEOG (indirect holdings)

Nassif Mikheal (CEO) purchased 370 indirectly-held shares of NEOGEN CORP (NEOG) at $11.81 on 2026-08-04.

Original reporting
SEC EDGAR · Nassif Mikheal
Published Aug 6, 2026, 12:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 12:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NEOG
Bullish
low confidence
Mentioned
$NEOG
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NEOGBullishLow
01

Why it matters

The CEO’s open-market purchase is a sentiment datapoint, but it does not include any new operational, financial, or regulatory information that would change valuation assumptions.

02

Market read

Traders may note the insider buy for sentiment, but the transaction size and lack of new fundamentals suggest limited trading impact.

03

What to watch

The article does not state the indirect holding structure details, and it provides no context on prior transactions or whether the purchase was part of broader compensation planning.

Relevance 3/10Novelty 3/10Timing: Form 4 filed 2026-08-06, covering a 2026-08-04 purchase.

Background

The article is a primary-source SEC Form 4 insider transaction disclosure for NEOGEN Corp.

Company-level read

Ticker impact

$NEOGBullishLow confidence
Context

NEOGEN CEO Nassif Mikheal bought 370 shares on 2026-08-04 for $4,369.70, disclosed via Form 4 filed 2026-08-06.

Expected impact

Likely limited, short-lived sentiment effect; no clear directional signal beyond optics.

Evidence & confidence

Form 4 insider buys can be read as confidence, but the disclosed size is small and the filing provides no new company performance or guidance.

Market effects

No sector-wide implications; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

Insider buys can be routine liquidity or tax-related, and the indirect nature of the holdings reduces interpretability.

Key entities

  • NEOGEN CORP

    Company whose CEO insider purchase is disclosed on Form 4.

  • Nassif Mikheal

    CEO and officer/director who reported an open-market purchase of 370 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

Med

Neogen Chemicals Ltd (BOM:542665) (Q2 2027) Earnings Call Highlights: 42% Revenue

Neogen Chemicals (BOM:542665) reported Q2 2027 earnings, with a 42% revenue surge. The company guided FY27 battery chemicals revenue at INR 250-300 crore and FY28 at over INR 1,000 crore. Base chemicals guidance for FY27 was upgraded to over INR 1,100 crore. Net debt for FY28 is expected to be INR 1,300-1,500 crore. The company is benefiting from US demand shifts due to tax credits and has secured customer approvals for lithium electrolyte salts.

$NEOGHigh

Neogen Corporation announced that it had entered into a definitive agreement to sell its global Genomics business to Zoetis Inc

NEOGEN CORP (NEOG) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. On March 2, 2026, Neogen Corporation (“ Neogen ”) announced that it had entered into a definitive agreement to sell its global Genomics business to Zoetis Inc. (“ Zoetis ”). This transaction is subject to customary closing conditions and regulatory approva